Evidence map›Paper›PMID 41846634›Full record

ArticleCureus2026

Self-Reported Treatment for Hearing Loss in Adults Living With or Without Human Immunodeficiency Virus (HIV).

Peter Torre Iii, Deanna Ware, Chukwuemeka N Okafor, Gayle Springer, Howard Hoffman, Christopher Cox, Michael Plankey

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peter Torre IiiSchool of Speech, Language, and Hearing Sciences, San Diego State University, San Diego, USA.
Deanna WareDepartment of Medicine, Georgetown University Medical Center, Washington, DC, USA.
Chukwuemeka N OkaforDepartment of Medicine, Division of Infectious Diseases, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, USA.
Gayle SpringerDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA.
Howard HoffmanDepartment of Epidemiology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, USA.
Christopher CoxDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA.
Michael PlankeyDepartment of Medicine, Georgetown University Medical Center, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) and its treatment have been associated with hearing loss. For those who can benefit from treatment for hearing loss (i.e., hearing aids), uptake for services is low, likely due to stigma. There is also stigma for people living with HIV (PWH). As such, it is not known how both hearing loss and HIV status affect whether or not adults seek treatment for hearing loss. Therefore, the purpose of this cross-sectional (PT1) study was to evaluate self-reported hearing ability and hearing loss treatment in middle-aged and aged PWH and people without HIV (PWOH). Participants in the Multicenter AIDS Cohort Study (MACS) Women's Interagency HIV Study (WIHS) Clinical Cohort Study (MWCCS) were asked questions related to their hearing ability and whether they sought hearing services. Among the 933 participants who reported hearing problems, 143 (15.3%) reported using hearing amplification; there was no difference by HIV serostatus. Almost 50% of participants who reported having a lot of trouble hearing did not report using any hearing amplification. Increased public education about hearing loss and amplification is needed, and this should come from audiologists and primary care physicians.

Indexed as

hearing losshearing treatmenthivmacs/wihs combined cohort studyself-report

Identifiers

PMID41846634
PMCPMC12989735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.